Back to search

Article

Life-long hydroxyurea treatment decreases chronic pain in sickle cell disease mice

2025-09-03

Abstract excerpt

Chronic sickle cell disease (SCD) pain mechanisms remain critically understudied, even though more than 50% of patients develop this symptom as their disease progresses. Despite high face validity, there are critical gaps in transgenic SCD mouse model characterization and implementation that must be addressed in order to increase the translational relevance of these animals. First, it is unclear when the chronic p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d9d2cc13-c34d-5918-8e56-26e39527820e
DOI
10.1101/2025.08.30.673263
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Life-long hydroxyurea treatment decreases chronic pain in sickle cell disease miceDOI 10.1101/2025.08.30.673263
Select a neighboring publication to make it the new centre.